John Traylor, MD
Anesthesiology · Southfield, MINPI 1760418784
Payments from drug & device makers
Across 410 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Scilex Pharmaceuticals Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Nevro Corp.$766
- Medtronic$601
- Collegium Pharmaceutical, Inc.$427
- plus $2K from 30 others
What the payments were for
- Food & beverage$7,710100%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 54 | $1,285 |
| Scilex Pharmaceuticals Inc. | 50 | $1,282 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 95 | $1,131 |
| Nevro Corp. | 28 | $766 |
| Medtronic(2 entities) | 22 | $601 |
| Collegium Pharmaceutical, Inc. | 27 | $427 |
| Forte Bio-pharma LLC | 36 | $328 |
| Globus Medical | 11 | $282 |
| Si-bone, Inc. | 4 | $212 |
| MDD US Operations, LLC | 14 | $204 |
| Pfizer | 19 | $171 |
| Medline Industries LP | 2 | $167 |
| Daiichi Sankyo Inc. | 8 | $127 |
| Vertex | 3 | $67 |
| Redhill Biopharma Inc. | 3 | $53 |
| Nalu Medical, Inc. | 2 | $52 |
| Vertos Medical, Inc. | 3 | $51 |
| Biodelivery Sciences International, Inc. | 4 | $49 |
| Abbott | 2 | $49 |
| USWM, LLC | 3 | $45 |
| Pacira Therapeutics, Inc. | 2 | $45 |
| Fidia Pharma USA Inc. | 2 | $42 |
| Tersera Therapeutics LLC | 2 | $33 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Neuros Medical, Inc. | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $18 |
| West Therapeutics Development, LLC | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Protega Pharmaceutials Inc | 1 | $13 |
| GRT US Holding, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,710 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 54 | $128,190 |
| ZtlidoLidocaine | 156 | $82,273 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,493 | $71,740 |
| Lidocaine | 640 | $55,078 |
| OxycontinOxycodone Hcl | 66 | $52,738 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,944 | $34,938 |
| MovantikNaloxegol Oxalate | 74 | $31,410 |
| Diclofenac Sodium | 314 | $20,681 |
| Gabapentin | 1,713 | $17,976 |
| BelbucaBuprenorphine Hcl | 32 | $17,906 |
| Nucynta ErTapentadol Hcl | 14 | $17,062 |
| Oxymorphone Hcl ErOxymorphone Hcl | 24 | $15,949 |
| Diclofenac Epolamine | 19 | $14,999 |
| Fentanyl | 127 | $14,192 |
| Buprenorphine | 51 | $12,682 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,131 | $128,19054 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,282 | $82,273156 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er | $427 | $34,96846 claims |
| Redhill Biopharma Inc.Movantik | $53 | $31,41074 claims |
| AbbVieSavella | $13 | $7,76511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,299 anesthesiology providers in Michigan.
Other anesthesiology in Southfield
- Jay GlobersonSouthfield$79K
- Jeffrey KimpsonSouthfield$13K
- Jack WagonerJackson$1.8M
- Sathish KumarAnn Arbor$870K
- Douglas ColquhounAnn Arbor$470K
- Carlos Guerra LondonoDetroit$367K
- Nirav ShahAnn Arbor$227K
- Neal DuggalAnn Arbor$206K
- Daniel LeeWarren$168K
- Shobha MalviyaAnn Arbor$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.